De L. Rubia
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.
Journal: Transplantation and cellular therapy
Published: November 12, 2025
Copy-Neutral Loss of Heterozygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism Arrays.
Journal: The Journal of molecular diagnostics : JMD
Published: September 09, 2025
Copy-Neutral Loss of Heterzygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism Arrays.
Journal: The Journal of molecular diagnostics : JMD
Published: September 09, 2025
Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: April 07, 2025
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: December 31, 2024
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: October 12, 2024
Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 29, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026